Holen Sie sich die Stockscreener-App
8.43
2.55%
0.21
Handel nachbörslich:
8.43
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. (RXST) Shareholders - PR Newswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - MarketScreener
RXST FRAUD REMINDER: RxSight, Inc. Stock Drop Triggers - GlobeNewswire
Live market analysis of RxSight Inc.Market Volume Summary & Real-Time Price Movement Reports - Newser
Using portfolio simulators with RxSight Inc. includedGold Moves & Growth Focused Stock Pick Reports - Newser
Can RxSight Inc. sustain earnings growthWeekly Gains Summary & High Accuracy Swing Entry Alerts - thegnnews.com
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference - 富途牛牛
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Eye Care Innovator RxSight Joins Major Wells Fargo Healthcare Conference in September - Stock Titan
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Class Action Filed Against RxSight, Inc. (RXST)September 22, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire
Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: RXST) - openPR.com
Shareholders who lost money on their RxSight, Inc. (NASDAQ: - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
RXSIGHT STOCK: Lose Money on Your RxSight, Inc. - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - FinancialContent
RxSight’s Earnings Call: Mixed Results Amid Growth and Challenges - MSN
RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript - MSN
RXST INVESTOR NOTICE: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - PR Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Morningstar
RxSight, Inc. and the Governance Crisis: Navigating Legal Storms and Shareholder Value Erosion - AInvest
RXSIGHT INVESTORS: Contact BFA Law about the RxSight, Inc. (RXST) Class Action before the September 22 Legal Deadline - Newsfile
Shareholders of RxSight, Inc. (RXST): Protect Your Rights Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages RxSight, Inc. - GlobeNewswire
Lost Money on RxSight, Inc. (RXST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Class Action Lawsuit Filed: RxSight, Inc. (RXST)Join by September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
RXST COURT NOTICE: RxSight, Inc. Investors may have been - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
RxSight, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - PR Newswire
Class Action Lawsuit Filed Against RxSight, Inc. (RXST)Recover LossesContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - 富途牛牛
Needham & Company LLC Cuts RxSight (NASDAQ:RXST) Price Target to $11.00 - Defense World
Investor Alert: Deadline Approaching to Join RxSight, Inc. (RXST) Class ActionContact Levi & Korsinsky - ACCESS Newswire
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is RxSight Inc. building a consolidation baseFree Buy Low Sell High Stock Watch - Newser
Should you hold or exit RxSight Inc. nowStable Swing Setup with Safety Analysis - Newser
RXST Investors Have Opportunity To Lead RxSight, Inc. Securities Fraud Lawsuit - Barchart.com
RXST NEWS: Did RxSight, Inc. Mislead Investors? Contact BFA - GlobeNewswire
Automated trading signals detected on RxSight Inc.Secure Asset Flow and Trend Pattern Analysis - Newser
RxSight's Strategic Reinvention: Can International Expansion and Product Innovation Justify a Re-Rating? - AInvest
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors – Contact Levi & Korsinsky - GlobeNewswire
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
UBS Adjusts RxSight Price Target to $8 From $16, Maintains Neutral Rating - MarketScreener
RxSight stock price target cut by UBS to $8 on weak LDD placements - Investing.com
RxSight Inc. (RXST) PT Lowered to $8 at UBS - StreetInsider
Earnings call transcript: Rxsight Q2 2025 reports wider loss, stock rises - Investing.com
RXST SHAREHOLDERS: RxSight, Inc. Stock Drop Triggers - GlobeNewswire
RxSight, Inc. Reports Q2 2025 Financial Results - TipRanks
RxSight’s Revenue Slips As Losses Grow But Margins Hold Steady - Finimize
RxSight, Inc. Presents Second Quarter 2025 Revenue, Reiterates Full-Year Guidance - VisionMonday.com
1.74%
0.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):